Medical News

RSS

HHF to open Terni Human Health Bioscience Institute

The Human Health Foundation, a nonprofit organization founded in 2006 to develop and fund biomedical research in Italy, will open the Terni Human Health Bioscience Institute for the investigation of breast, brain and lung cancer on June 7th in Terni, Italy.

5 Jun 2010

Survey: Group insurance rates rise for employers

"Group health insurance rates for small and midsize employers are surging for 2011 renewals, according to a survey by the Council of Insurance Agents & Brokers," Business Insurance reports.

5 Jun 2010

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

Pacific Edge (PEB), a New Zealand-based biomedical company, today announced the successful completion of the European clinical trial for their prognostic gene signature for colorectal cancer. The clinical trial results showed a successful outcome that enables patients diagnosed with UICC stage II or UICC stage III colorectal cancer and with a high risk of disease progression to be identified and treated more appropriately.

5 Jun 2010

VA partners with National Institutes of Health to research on Parkinson's disease

Veterans and others with Parkinson's disease who undergo deep brain stimulation may benefit from research co-sponsored by the Department of Veterans Affairs and published recently in the prestigious New England Journal of Medicine.

5 Jun 2010

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

Sucampo Pharmaceuticals, Inc. today confirmed that its partner, R-Tech Ueno, Ltd. reported the results of its recently completed phase 2 clinical trial of UF-021 in retinitis pigmentosa patients. The results showed improvement in visual function dose-dependently in both visual field test and subjective findings.

5 Jun 2010

Insurers, White House bound by need to make overhaul a success

Although the Obama administration and insurance industry had opposing views on aspects of the health bill that Congress eventually passed, they have now found their fortunes bound together as both work to make the overhaul successful, The New York Times reports. "The political fortunes of President Obama and Congressional Democrats depend on their ability to translate its promise into reality for voters, by reining in health costs and making insurance available to everyone at an affordable price.

5 Jun 2010

Obama sets town hall meeting with seniors to tout Medicare rebate checks

President Barack Obama has scheduled a televised town hall meeting Tuesday in Wheaton, Md., "to trumpet one of the most popular provisions of his landmark health care bill: a $250 rebate to help Medicare beneficiaries pay for prescription drugs. ... An estimated 80,000 checks are scheduled to be sent in June, with others to follow on a rolling basis, to Medicare beneficiaries who enter the so-called 'doughnut hole' - a gap in prescription drug coverage that requires them to pay out of pocket" (Stolberg, 6/3).

5 Jun 2010

Endologix named as Orange County's Outstanding Company in Medical Technology

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA.

5 Jun 2010

United American Insurance introduces new 2010 Medicare Supplement plans

United American Insurance Company recently announced the introduction of new 2010 Medicare Supplement standardized plans that meet the requirements set forth by the Medicare Improvements for Patients and Providers Act of 2008. In general, United American's Medicare Supplement products are attained-age, gender-distinct, smoker/nonsmoker, and geographic area rated.

5 Jun 2010

Mylan subsidiary receives FDA approval for generic version of Neurontin Tablets

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin Tablets for the treatment of postherpetic neuralgia, a complication of shingles.

5 Jun 2010

States to curb retiree benefits in search of savings

States are seeking savings in public employee retiree benefits to close sprawling budget gaps, Bloomberg Businessweek reports. "New Jersey and 20 other states are urging early retirements, cutting benefits and demanding employees contribute more in the face of what the Pew Center on the States says is a $1 trillion gap between available assets and what's owed workers."

5 Jun 2010

Imaging Dynamics announces rights offering

Imaging Dynamics Company Ltd., a global supplier in the high growth digital radiography (DR) equipment market, announced that it has filed a preliminary short form prospectus dated June 3, 2010 to issue rights to all shareholders at the applicable record date to purchase common shares of the Company.

5 Jun 2010

Health care quality issues: The disconnect between patients and experts

Improving "health literacy" could help improve patient outcomes and quality. This literacy is "the limited ability to understand the technical jargon, the orders, the prescriptions and the forms coming from doctors, nurses, pharmacists and insurance companies. This failure to communicate leads to missed doctor appointments, medications taken incorrectly, instructions ignored — all contributing to worsening health."

5 Jun 2010

Researchers present clinical outcomes of lenalidomide in patients with large B-cell lymphoma

Celgene International Sàrl today announced researchers at the annual meeting of the American Society of Clinical Oncology presented data from an evaluation of lenalidomide (REVLIMID) in patients with diffuse large B-cell lymphoma either with a germinal center B-cell or non-germinal center B-cell phenotype.

5 Jun 2010

N.J. court case examines end-of-life decisions

The Wall Street Journal: A New Jersey court is weighing if the life of Ruben Betancourt "should have been prolonged and who should have made that decision: the hospital or his family." In a lawsuit, "his daughter, Jacqueline Betancourt, contends that her father was aware of his family's presence and that the hospital had no right to terminate life support without the family's agreement."

5 Jun 2010

AHF applauds Gilead for offering pricing, access concessions to AIDS Drug Assistance Programs

AIDS Healthcare Foundation (AHF) lauded Gilead Sciences, maker of several key AIDS drugs, for its announcement earlier today that it will offer significant pricing and access concessions for the nation's beleaguered AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.

5 Jun 2010

AMA launches ads pushing Senators on 'doc fix' while warning on cuts

The American Medical Association has launched a multi-million-dollar series of ads pressuring senators to intervene to prevent a scheduled payment cut for doctors who treat Medicare patients and warning that a separate permanent fix of the system is the only way to completely ensure continuity of care for seniors.

5 Jun 2010

Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Competitive Technologies, Inc. announced today that the Walter Reed Army Medical Center in Washington, D.C., has joined the growing list of organizations that will treat pain patients with CTT's Calmare Pain Therapy Treatment, as authorized by the Surgeon General of the U.S. Army and Commanding General of the U.S. Army Medical Command.

5 Jun 2010

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Biomet, a global leader in the manufacture of orthopedic and biotechnology products, announced today that its subsidiary, Biomet Biologics, has enrolled the first subject into its multicenter, prospective, randomized, double-blind, placebo-controlled clinical trial for critical limb ischemia (CLI).

5 Jun 2010

Boston hospitals increasingly scrutinized for costs while Buffalo hospitals will receive more Medicare funding

Officials in Gov. Deval Patrick's administration, "seeking to pressure hospitals as well as insurers to rein in costs, say they will more closely scrutinize plans for new medical buildings and technologies to determine how they might affect the cost of health care in Massachusetts.

5 Jun 2010

Medical News

HHF to open Terni Human Health Bioscience Institute

Survey: Group insurance rates rise for employers

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

VA partners with National Institutes of Health to research on Parkinson's disease

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

Insurers, White House bound by need to make overhaul a success

Obama sets town hall meeting with seniors to tout Medicare rebate checks

Endologix named as Orange County's Outstanding Company in Medical Technology

United American Insurance introduces new 2010 Medicare Supplement plans

Mylan subsidiary receives FDA approval for generic version of Neurontin Tablets

States to curb retiree benefits in search of savings

Imaging Dynamics announces rights offering

Health care quality issues: The disconnect between patients and experts

Researchers present clinical outcomes of lenalidomide in patients with large B-cell lymphoma

N.J. court case examines end-of-life decisions

AHF applauds Gilead for offering pricing, access concessions to AIDS Drug Assistance Programs

AMA launches ads pushing Senators on 'doc fix' while warning on cuts

Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Boston hospitals increasingly scrutinized for costs while Buffalo hospitals will receive more Medicare funding

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News